---
layout: theophylline_style
title: J6f1 aptamer
date: 2024-05-20 00:00:00
author: Linfei Li, Yuhang Luo
categories: Aptamer
tags:
- Category:Pharmaceuticals
- GC:52.5
- Length:40
- Named:Tobramycin_J6f1
- Type:Small molecules
- Year:1998
type: Small molecules
---
<html>


<div class="side-nav">
<ul>
    <div class="side-nav-item"><li><a href="#description" style="color: #000000;">Description</a></li></div>
    <div class="side-nav-item"><li><a href="#SELEX" style="color: #000000;">SELEX</a></li></div>
    <div class="side-nav-item"><li><a href="#Structure" style="color: #000000;">Structure</a></li></div>
    <div class="side-nav-item"><li><a href="#ligand-recognition" style="color: #000000;">Ligand information</a></li></div>
    <div class="side-nav-item"><li><a href="#references" style="color: #000000;">References</a></li></div>
    </ul>
</div>



<p class="header_box" id="description">Description</p>
<p>In 1995, Wang, Y., & Rando, R. R. reported on the selection of RNA aptamers which were directed against the aminoglycoside tobramycin. In 1998, Hamasaki and Rando were reported here which are designed to reveal the nature of the tobramycin binding domain of J6. Experiments was reported here which was designed to reveal the nature of the tobramycin binding domain of J6 aptamer. A small (40 nts) stem-loop derivative of J6 aptamer, containing a 3 nt and a 1 nt bulge, stoichiometrically binds tobramycin with a dissociation constant of approximately 5 nM. These studies demonstrated that simplified RNA molecules can be generated which bind aminoglycosides specifically and with high affinities. J6f1 is a truncated mutant of J6 aptamer<sup>[<a href="#ref1" style="color:#520049">1</a>,<a href="#ref3" style="color:#520049">3</a>]</sup>.<br></p>


<p class="header_box" id="SELEX">SELEX</p>
<p>Rando, R. R. et al. used SELEX to isolate high-affinity RNA aptamers that specifically bind the aminoglycoside tobramycin. Starting from a 109-nucleotide aptamer (J6) with a dissociation constant of 0.77 ± 0.03 nM for tobramycin, they simplified the construct to a 39-nucleotide aptamer (J6e) that retained high affinity (KD = 58.2 ± 13.1 nM) and specificity for tobramycin. Further modifications led to a 40-nucleotide aptamer (J6f1) with a KD of 5.15 ± 1.52 nM, demonstrating that simplified RNA constructs can maintain high-affinity and specific aminoglycoside binding<sup>[<a href="#ref3" style="color:#520049">3</a>]</sup>.</p>
<p>


<p class="header_box" id="Structure">Structure</p>
<p>The sequence and secondary prediction structure of the aptamer will be shown here, here we used ribodraw to complete the figure. The 2D structure of the figures is based on the prediction results of the RNA fold website by ribodraw tool to draw. J6f1 aptamer was named by Rando, R. R. et al<sup>[<a href="#ref3" style="color:#520049">3</a>]</sup>.</p>
<p>5'-GGCUUAGUAUAGCGAGGUUUAGCUACACUCGUGCUGAGCC-3'</p>
<img src="/images/2D/J6f1_aptamer_2D.svg" alt="drawing" style="width:800px;height:350px;display:block;margin:0 auto;border-radius:0;" class="img-responsive">
<div style="display: flex; justify-content: center;"></div>




<p class="header_box" id="ligand-recognition">Ligand information</p> 

<p class="blowheader_box">SELEX ligand</p>
<p>Tobramycin is an aminoglycoside antibiotic used to treat cystic fibrosis-associated bacterial, lower respiratory tract, urinary tract, eye, skin, bone, and skin structure infections.-----From <a href="https://go.drugbank.com/drugs/DB00684" target="_blank" style="color:#520049; text-decoration: underline;"><b>Drugbank</b></a></p>

<p class="dot-paragraph"><b>PubChem CID:</b> a unique identifier for substances in the <a href="https://pubchem.ncbi.nlm.nih.gov/" target="_blank" style="color:#520049; text-decoration: underline;"><b>PubChem database</b></a>.</p>
<p class="dot-paragraph"><b><a href="https://commonchemistry.cas.org/" target="_blank" style="color:#520049; text-decoration: underline;"><b>CAS</b></a> number:</b> a global registry number for chemical substances.</p>
<p class="dot-paragraph"><b><a href="https://go.drugbank.com/" target="_blank" style="color:#520049; text-decoration: underline;"><b>Drugbank</b></a>:</b> a comprehensive database with detailed information on drugs and drug targets.</p>

<table class="table table-bordered" style="table-layout:fixed;width:auto;margin-left:auto;margin-right:auto;" >
  <thead>
      <tr>
        <th onclick="sortTable(0)">Name</th>
        <th onclick="sortTable(1)">Molecular Formula</th>
        <th onclick="sortTable(2)">Molecular Weight</th>
        <th onclick="sortTable(3)">CAS</th>
        <th onclick="sortTable(4)">Solubility</th>
        <th onclick="sortTable(5)">PubChem</th>
        <th onclick="sortTable(6)">Drugbank ID</th>
      </tr>
  </thead>
    <tbody>
      <tr>
        <td name="td0">Tobramycin</td>
        <td name="td1">C<sub>18</sub>H<sub>37</sub>N<sub>5</sub>O<sub>9</sub></td>
        <td name="td2">467.5 g/mol</td>
        <td name="td3"><a href="https://commonchemistry.cas.org/detail?cas_rn=32986-56-4" target="_blank" style="color:#520049"><b>32986-56-4</b></a></td>
        <td name="td4">5.37e+01 g/L</td>
        <td name="td5"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/36294" target="_blank" style="color:#520049"><b>36294</b></a></td>
        <td name="td6"><a href="https://go.drugbank.com/drugs/DB00684" target="_blank" style="color:#520049"><b>DB00684</b></a></td>
      </tr>
	  </tbody>
  </table>
<div style="display: flex; justify-content: center;"></div>
<img src="/images/SELEX_ligand/J6f1_aptamer_SELEX_ligand.svg" alt="drawing" style="width:1000px;height:400px;border:solid 1px #efefef;display:block;margin:0 auto;border-radius:0;" class="img-responsive">
<div style="display: flex; justify-content: center;"></div>
<br>


<p class="blowheader_box">Similar compound</p>                    
<p>We screened the compounds with great similarity to  by using the <a href="https://zinc15.docking.org/" target="_blank" style="color:#520049; text-decoration: underline;"><b>ZINC database</b></a> and showed some of the compounds' structure diagrams. For some CAS numbers not available, we will supplement them with Pubchem CID. For another compound, we used a similar compound query method from the PubChem database.</p>

<p class="dot-paragraph"><b>ZINC ID:</b> a compound identifier used by the <a href="https://zinc15.docking.org/" target="_blank" style="color:#520049; text-decoration: underline;"><b>ZINC database</b></a>, one of the largest repositories for virtual screening of drug-like molecules.</p>
<p class="dot-paragraph"><b>PubChem CID:</b> a unique identifier for substances in the <a href="https://pubchem.ncbi.nlm.nih.gov/" target="_blank" style="color:#520049; text-decoration: underline;"><b>PubChem database</b></a>.</p>
<p class="dot-paragraph"><b><a href="https://commonchemistry.cas.org/" target="_blank" style="color:#520049; text-decoration: underline;"><b>CAS</b></a> number:</b> a global registry number for chemical substances.</p>

<table class="table table-bordered" style="table-layout:fixed;width:auto;margin-left:auto;margin-right:auto;">
      <thead>
      <tr>
        <th onclick="sortTable(0)">ZINC ID</th>
        <th onclick="sortTable(1)">Name</th>
        <th onclick="sortTable(2)">CAS</th>
        <th onclick="sortTable(3)">Pubchem CID</th>
        <th onclick="sortTable(4)">Structure</th>
      </tr>
      </thead>
    <tbody>
      <tr>
        <td name="td0"><a href="https://zinc15.docking.org/substances/ZINC8551162/" target="_blank" style="color:#520049"><b>ZINC8551162</b></a></td>
        <td name="td1">(2R,3S,4R,5S,6S)-4-amino-2-[(1R,2R,3R,4S,6R)-4,6-diamino-3-[(2S,3S,5S,6S)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-dio</td>
        <td name="td2">NA</td>
        <td name="td3"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/92331686" target="_blank" style="color:#520049"><b>92331686</b></a></td>
        <td name="td4"><img src="/images/Similar_compound/J6f1_Simi_compound1.svg" alt="drawing" style="width:500px"  px="" /></td>
      </tr>
      <tr>
        <td name="td0"><a href="https://zinc15.docking.org/substances/ZINC8551164/" target="_blank" style="color:#520049"><b>ZINC8551164</b></a></td>
        <td name="td1">(2R,3S,4R,5S,6S)-4-amino-2-[(1R,2R,3R,4S,6R)-4,6-diamino-3-[(2R,3S,5S,6S)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol</td>
        <td name="td2">NA</td>
        <td name="td3"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/92331688" target="_blank" style="color:#520049"><b>92331688</b></a></td>
        <td name="td4"><img src="/images/Similar_compound/J6f1_Simi_compound2.svg" alt="drawing" style="width:500px"  px="" /></td>
      </tr>
      <tr>
        <td name="td0"><a href="https://zinc15.docking.org/substances/ZINC8551165/" target="_blank" style="color:#520049"><b>ZINC8551165</b></a></td>
        <td name="td1">(2R,3S,4R,5S,6S)-4-amino-2-[(1R,2R,3R,4S,6R)-4,6-diamino-3-[(2R,3S,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol</td>
        <td name="td2">NA</td>
        <td name="td3"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/92331689" target="_blank" style="color:#520049"><b>92331689</b></a></td>
        <td name="td4"><img src="/images/Similar_compound/J6f1_Simi_compound3.svg" alt="drawing" style="width:500px"  px="" /></td>
      </tr>
      <tr>
        <td name="td0"><a href="https://zinc15.docking.org/substances/ZINC8551163/" target="_blank" style="color:#520049"><b>ZINC8551163</b></a></td>
        <td name="td1">(2R,3S,4R,5S,6S)-4-amino-2-[(1R,2R,3R,4S,6R)-4,6-diamino-3-[(2S,3S,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol</td>
        <td name="td2">NA</td>
        <td name="td3"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/92331687" target="_blank" style="color:#520049"><b>92331687</b></a></td>
        <td name="td4"><img src="/images/Similar_compound/J6f1_Simi_compound4.svg" alt="drawing" style="width:500px"  px="" /></td>
      </tr>
      <tr>
        <td name="td0"><a href="https://zinc15.docking.org/substances/ZINC43562055/" target="_blank" style="color:#520049"><b>ZINC43562055</b></a></td>
        <td name="td1">(2S,3R,4R,5S,6S)-2-(Aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol</td>
        <td name="td2">NA</td>
        <td name="td3"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/11274101" target="_blank" style="color:#520049"><b>11274101</b></a></td>
        <td name="td4"><img src="/images/Similar_compound/J6f1_Simi_compound5.svg" alt="drawing" style="width:500px"  px="" /></td>
      </tr>
      <tr>
        <td name="td0"><a href="https://zinc15.docking.org/substances/ZINC8214590/" target="_blank" style="color:#520049"><b>ZINC8214590</b></a></td>
        <td name="td1">Kanamycin</td>
        <td name="td2"><a href="https://commonchemistry.cas.org/detail?cas_rn=59-01-8" target="_blank" style="color:#520049"><b>59-01-8</b></a></td>
        <td name="td3"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/6032" target="_blank" style="color:#520049"><b>6032</b></a></td>
        <td name="td4"><img src="/images/Similar_compound/J6f1_Simi_compound6.svg" alt="drawing" style="width:500px"  px="" /></td>
      </tr>
      <tr>
        <td name="td0"><a href="https://zinc15.docking.org/substances/ZINC53132258/" target="_blank" style="color:#520049"><b>ZINC53132258</b></a></td>
        <td name="td1">Bekanamycin</td>
        <td name="td2"><a href="https://commonchemistry.cas.org/detail?cas_rn=4696-76-8" target="_blank" style="color:#520049"><b>4696-76-8</b></a></td>
        <td name="td3"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/439318" target="_blank" style="color:#520049"><b>439318</b></a></td>
        <td name="td4"><img src="/images/Similar_compound/J6f1_Simi_compound7.svg" alt="drawing" style="width:500px"  px="" /></td>
      </tr>
      <tr>
        <td name="td0"><a href="https://zinc15.docking.org/substances/ZINC8214383/" target="_blank" style="color:#520049"><b>ZINC8214383</b></a></td>
        <td name="td1">Dibekacin</td>
        <td name="td2"><a href="https://commonchemistry.cas.org/detail?cas_rn=34493-98-6" target="_blank" style="color:#520049"><b>34493-98-6</b></a></td>
        <td name="td3"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/470999" target="_blank" style="color:#520049"><b>470999</b></a></td>
        <td name="td4"><img src="/images/Similar_compound/J6f1_Simi_compound8.svg" alt="drawing" style="width:500px"  px="" /></td>
      </tr>
    </tbody>
  </table>
                 
<p class="header_box" id="references">References</p>
                
<a id="ref1"></a><font><strong>[1] Specific binding of aminoglycoside antibiotics to RNA.</strong></font><br/>
Wang, Y., & Rando, R. R.<br/>
<a href="https://pubmed.ncbi.nlm.nih.gov/9383430/" target="_blank" style="color:#520049">Chemistry & biology, 2(5), 281–290. (1995)</a>
<br/>

<a id="ref2"></a><font><strong>[2] RNA molecules that specifically and stoichiometrically bind aminoglycoside antibiotics with high affinities.</strong></font><br/>
Wang, Y., Killian, J., Hamasaki, K., & Rando, R. R. <br/>
<a href="https://pubmed.ncbi.nlm.nih.gov/8823168/" target="_blank" style="color:#520049">Biochemistry, 35(38), 12338–12346. (1996)</a>
<br/>

<a id="ref3"></a><font><strong>[3] Minimal RNA constructs that specifically bind aminoglycoside antibiotics with high affinities.</strong></font><br/>
Hamasaki, K., Killian, J., Cho, J., & Rando, R. R.<br/>
<a href="https://pubmed.ncbi.nlm.nih.gov/9425088/" target="_blank" style="color:#520049">Biochemistry, 37(2), 656–663. (1998)</a>
<br/>